Financhill
Back

Chemomab Therapeutics Stock Predictions

Chemomab Therapeutics Stock Forecast

  • Is Chemomab Therapeutics Stock Undervalued?
    The current Chemomab Therapeutics [CMMB] share price is $1.20. The Score for CMMB is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • CMMB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Chemomab Therapeutics Stock Go Up Next Year?

Data Unavailable

Chemomab Therapeutics Stock Rating

Data Unavailable

Chemomab Therapeutics Stock Price History

Is CMMB stock going to rise?

  • The current trend is moderately bearish and CMMB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
chemomab.com

52-Week Data

52-Week High:
2.55
52-Week Low:
0.78

Prediction Charts

Market Cap:
22.6M
Price in USD:
1.20
Volume:
72.3K
Beta:
0.69

Technical Analysis

SMA50:
1.25
SMA100:
1.46
SMA200:
1.58
52-Wk Change:
4.35%

Stock Predictions

  • Is Chemomab Therapeutics stock public?
    Yes, Chemomab Therapeutics is a publicly traded company.
  • What is the Chemomab Therapeutics stock quote today?
    The Chemomab Therapeutics stock price is 1.20 USD today.
  • How to buy Chemomab Therapeutics stock online?
    You can buy Chemomab Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-27 1.38 1.40 1.44 1.37
May-28 1.43 1.37 1.43 1.36
May-29 1.37 1.36 1.39 1.36
May-30 1.35 1.32 1.35 1.29
Jun-2 1.30 1.35 1.36 1.29
Jun-3 1.35 1.34 1.37 1.22
Jun-4 1.38 1.35 1.38 1.33
Jun-5 1.35 1.32 1.35 1.29
Jun-6 1.30 1.32 1.37 1.30
Jun-9 1.33 1.32 1.34 1.24
Jun-10 1.29 1.30 1.35 1.26
Jun-11 1.28 1.20 1.29 1.20
Jun-12 1.21 1.22 1.25 1.20
Jun-13 1.19 1.20 1.24 1.19

Chemomab Therapeutics Earnings

Data Unavailable

Chemomab Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.01 per share.

* Chemomab Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.